Chris Sarko

In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal disease

Brian L. Lin, Damian Matera, Julia F. Doerner et al. · Proceedings of the National Academy of Sciences · 2019 · 149 citations · Full text

Medicine, Cardiology, Pharmacology +17

DABIGATRAN ANTICOAGULANT ACTIVITY IS NEUTRALIZED BY AN ANTIBODY SELECTIVE TO DABIGATRAN IN IN VITRO AND IN VIVO MODELS

Joanne van Ryn, Tobias Litzenburger, Alisa Waterman et al. · Journal of the American College of Cardiology · 2011 · 79 citations

Pharmacy, Pharmacokinetics, Pharmacology +9

A Soluble Guanylate Cyclase Activator Inhibits the Progression of Diabetic Nephropathy in the ZSF1 Rat

Carine M. Boustany‐Kari, Paul C. Harrison, Hu Sheng Qian et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 56 citations · Full text

Medicine, Nephrology, Pharmacology +16

Indole RSK inhibitors. Part 1: Discovery and initial SAR

Stephen J. Boyer, Jennifer Burke, Xin Guo et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

The Novel, Clinical-Stage Soluble Guanylate Cyclase Activator BI 685509 Protects from Disease Progression in Models of Renal Injury and Disease

Glenn A. Reinhart, Paul C. Harrison, Kathleen Lincoln et al. · Journal of Pharmacology and Experimental Therapeutics · 2022 · 29 citations · Full text

Medicine, Nephrology, Pharmacology +16